Case 1st Author Pt. Age (yr) Primary Lesion Extra-uterine Recurrence or progression Prognosis after Recurrence
Histology & Stage Treatment Site Time Histology
1 Duska[1] 31 EA G1. stage LA Progestins Ovary At least after term pregnancy EA NA
2 Kaku [2] 36 EA G1. stage LA MPA 600 mg/day ltObcurator IN 22 mo NA Ned 38 mo
3 Yasuda [3] 31 AEH MPA 600 mg/day, 7 mo Retroperitoneal IN/ Multiple Organ Metastasis 36 mo EAG3 with partly germ cell differentiation DOD 7 mo
4 Huang [4] 36 EA G1. stage LA MA 160 mg/day, 1mo + TMX20 mg/day, 2 mo + d LA 3.75 mg/mo, 2 mo rt Ovary 2 more mo of TMX + dLA EA. G1 NED
5 Rubatt [5] 40 AEH MA 80 mg2W + LNG/EE forĀ  3mo and until recurrence Light pelvic Ins Positive peritoneal cytology 30 mo EA. G2 NED 12 mo
6 Yang [6] 30 EA G1. stage LA MA 160 MPA 400 mg/day, 5mo Ovary 5 mo EA NED
7 Yang [6] 37 EA G1. stage LA MA 160 MPA 400 mg/day, 2mo Ovary 4 mo EA NED
8 Forrandina[7] 30 EA G1. stage LA Cyclic DG 20 MPA 400 mg/day, 3 mo Lung/Liver/Bone Retroperitoneal LN 14 mo
(9 moafter C/S)
EA. G3 DOD 10 mo
9 Cormio [8] 31 EA G1. stage LA MA320 MPA 400 mg/day Lung/Pelvis/Orbit/Brain 36 mo EA. G1 DOD 7 mo
10 Yamazawa [9] 33 EA G1. stage LA MPA 400 mg/day, 6 mo rt Ovary 10 mo EA. G1 NED 69 mo
11 Yamazawa [9] 38 EA G1. stage LA MPA 400 mg/day, 6M rt Ovary 22 mo EA. G1 NED 39 mo
12 Ushijima[10] 20-39 EA G1. stage LA MPA 600 mg/day PeritonieaCalcinomatosis 24 mo EA. G2 DOD 4 mo
13 Kothari[11] 24 EA G2. stage LA Ma160 mg/day, 6 mo +ING.IUD Pelvic Implants 21+6 mo EA. G1 NED 24 mo
Table 2: Cases with extrauterine recurrence after temporary remission of endometrioid adenocarcinoma or atypical endometrial hyperplasia.
Goto home»